US FDA nod for Ocrevus (ocrelizumab) shorter 2-hour infusion for relapsing and primary progressive MS

Read more

US begins COVID-19 vaccinations

Read more

EQT makes $2.8 bn bid for Recipharm

Read more

Sputnik V vaccine efficacy is 91.4 per cent: RDIF, Gamaleya Center

Read more

Moderna signs supply agreement with Singapore for COVID-19 vaccine

Read more

Himalaya study finds herbal immunomodulators effective as adjuvant treatment for COVID-19

Read more

IPA releases report titled, ‘Beyond Business: Contributions to Social Initiatives’

Read more

Ruxolitinib (Jakafi) does not prevent complications due to COVID-19 associated cytokine storm: Study

Read more

US begins transportation of COVID-19 vaccine to distribution points around the country

Read more

Biocon Biologics, Mylan get CHMP recommendation for approval of biosimilar insulin Aspart

Read more